EcoDrugPlus

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSFOG00015013610
Gene Symbol: FYN
3 Cross references
132 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSSFOG00015009808
Gene Symbol: GPR119
3 Cross references
174 Possible Orthologues:

G Protein-Coupled Receptor 84

Ensembl ID : ENSSFOG00015014575
Gene Symbol: GPR84
3 Cross references
124 Possible Orthologues:

G1/s-Specific Cyclin-D1-Like

Ensembl ID : ENSSFOG00015011800
Gene Symbol: LOC108940463
3 Cross references
233 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSFOG00015017090
Gene Symbol: HCK
3 Cross references
202 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSSFOG00015016656
Gene Symbol: ITK
3 Cross references
207 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSSFOG00015012910
Gene Symbol: JAK1
1 Cross references
233 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSSFOG00015001377
Gene Symbol: JAK1
3 Cross references
233 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSSFOG00015007323
Gene Symbol: JAK2
3 Cross references
194 Possible Orthologues:

Janus Kinase 2a

Ensembl ID : ENSSFOG00015022973
Gene Symbol: JAK2A
1 Cross references
199 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSSFOG00015017500
Gene Symbol: KIT
3 Cross references
205 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSSFOG00015023903
Gene Symbol: KRAS
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).